Harnessing the increasingly important applications of artificial intelligence, researchers from Genentech and parent company Roche have developed what is being called the first “deep learning model” that can predict which patients with diabetic retinopathy will progress the fastest.

A new study shows first-time proof that AI can detect the severity of diabetic macular edema, which is a leading cause of blindness.

Nearly two-thirds of U.S. doctors feel burned out, depressed, or both – and those feelings affect how they relate to patients, according to a survey conducted by Medscape.